Rainer Buchholz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rainer Buchholz has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ruth Freitag
Process Biotechnology, Faculty of Engineering Sciences, University of Bayreuth, Bayreuth, Germany
2 shared publications - Valérie Jérôme
Process Biotechnology, Faculty of Engineering Sciences, University of Bayreuth, Bayreuth, Germany
2 shared publications Christine Friedl
1 shared publicationH. Hübner
Institute of Bioprocess Engineering Friedrich‐Alexander University Erlangen‐Nürnberg Germany
1 shared publication- Hans-Martin Jäck
Division of Molecular Immunology, Department of Internal Medicine 3, Friedrich-Alexander University of Erlangen-Nürnberg, 91054 Erlangen, Germany
1 shared publication Holger Hübner
Institute of Bioprocess Engineering, Friedrich‐Alexander‐University Erlangen Nürnberg Paul‐Gordan‐Straße 3 Erlangen D‐91054 Germany
1 shared publication
Latest Publications
- 1 September 2017
- Published by Elsevier in Algal Research
- Vol. 26, 323-329
Chemical regulation of Fea1 driven transgene expression in Chlamydomonas reinhardtii
- 1 September 2017
- Published by Elsevier in Algal Research
- Vol. 26, 323-329
Chemical regulation of Fea1 driven transgene expression in Chlamydomonas reinhardtii
- 24 March 2016
- Published by Wiley in Biotechnology Progress
- Vol. 32 (4) , 978-989
Prolonged Ex vivo expansion and differentiation of naïve murine CD43− B splenocytes
Ex vivo expansion of naive primary B cells is still a challenge, yet would open new possibilities for in vitro studies of the immune response or the production of monoclonal antibodies. In our hands, unstimulated murine B cells did not expand in significant numbers, while culture viability decreased rapidly within a few days. Activation mimicking in vivo stimulation through either T cell‐independent or T‐cell dependent signaling, led to several division cycles, albeit accompanied by irreversible differentiation. By co‐culturing B cells under moderate hypothermia (30°C) on live feeder fibroblasts expressing recombinant CD40 ligand (CD154) and by repeatedly transferring cultured B cells to new feeder cell cultures, we could extend the growth of primary mouse B cells compared to cultures maintained at 37°C. B cells under these conditions showed an activated phenotype as shown by the presence of AID and IRF4, two factors required for IgH class switch recombination in antigen‐activated B cells. In contrast to cells cultured at 37°C, B cells under hyperthermia did surprisingly not differentiate into Blimp‐1 expressing plasmablasts. Thus, the repeated batch process under hyperthermic conditions represents a first step towards the development of a continuous cultivation system for the expansion of primary B cells. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:978–989, 2016
- 24 March 2016
- Published by Wiley in Biotechnology Progress
- Vol. 32 (4) , 978-989
Prolonged Ex vivo expansion and differentiation of naïve murine CD43− B splenocytes
Ex vivo expansion of naive primary B cells is still a challenge, yet would open new possibilities for in vitro studies of the immune response or the production of monoclonal antibodies. In our hands, unstimulated murine B cells did not expand in significant numbers, while culture viability decreased rapidly within a few days. Activation mimicking in vivo stimulation through either T cell‐independent or T‐cell dependent signaling, led to several division cycles, albeit accompanied by irreversible differentiation. By co‐culturing B cells under moderate hypothermia (30°C) on live feeder fibroblasts expressing recombinant CD40 ligand (CD154) and by repeatedly transferring cultured B cells to new feeder cell cultures, we could extend the growth of primary mouse B cells compared to cultures maintained at 37°C. B cells under these conditions showed an activated phenotype as shown by the presence of AID and IRF4, two factors required for IgH class switch recombination in antigen‐activated B cells. In contrast to cells cultured at 37°C, B cells under hyperthermia did surprisingly not differentiate into Blimp‐1 expressing plasmablasts. Thus, the repeated batch process under hyperthermic conditions represents a first step towards the development of a continuous cultivation system for the expansion of primary B cells. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:978–989, 2016
- 5 June 2014
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 111 (12) , 2571-2579
Cell retention by encapsulation for the cultivation of Jurkat cells in fixed and fluidized bed reactors
Jurkat cells are accepted model cells for primary human T lymphocytes, for example, in medical research. Their growth to tissue‐like cell densities (up to 100 × 106 cells/mLcapsule) in semi‐permeable (molecular weight cut off 6 cell/gcapsule. At the same time, the cell cycle distribution of the cells was shifted to the S and G2/M phases. Biotechnol. Bioeng. 2014;111: 2571–2579.
- 5 June 2014
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 111 (12) , 2571-2579
Cell retention by encapsulation for the cultivation of Jurkat cells in fixed and fluidized bed reactors
Jurkat cells are accepted model cells for primary human T lymphocytes, for example, in medical research. Their growth to tissue‐like cell densities (up to 100 × 106 cells/mLcapsule) in semi‐permeable (molecular weight cut off 6 cell/gcapsule. At the same time, the cell cycle distribution of the cells was shifted to the S and G2/M phases. Biotechnol. Bioeng. 2014;111: 2571–2579.